Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

Trinean to Enter into Global Supply Agreement with QIAGEN

Published: Tuesday, January 21, 2014
Last Updated: Tuesday, January 21, 2014
Bookmark and Share
Trinean to manufacture and supply the QIAxpert - a micro-volume spectrometer for DNA and RNA quantitation and quality analysis.

Trinean has announced that it has entered into a manufacturing and supply agreement with QIAGEN for the production of the QIAxpert, a micro-volume spectrometer for DNA and RNA quantitation and quality analysis.

This platform is a UV/VIS spectrophotometer which contains tailor-made solution for QIAGEN customers using QIAGEN’s DNA and RNA sample technologies and devices for quality control applications.

“We are very pleased with this agreement between QIAGEN and Trinean,” comments Philippe Stas, CEO of Trinean. "Adoption of our technology by QIAGEN, the market leader in DNA and RNA sample technologies, is an important new step in the global validation of our innovative take on UV-VIS spectroscopy.”

“Quality control (QC) is becoming increasingly important in nucleic acid based testing as novel detection technologies become more and more sensitive.” Dietrich Hauffe, Senior VP ,Head of Business Area Life Sciences at QIAGEN adds.

“The QIAxpert system provides a unique combination of accurate quantification and the capability to discriminate between molecules of interest. The system allows us to match high-performance sample technologies, in particular isolation, extraction and purification with high-speed spectrophotometry for confirmatory purposes. It will contribute to superior data output across all analytical workflows using DNA or RNA, from PCR to next generation sequencing. QIAxpert can also allow our customers to make better informed decisions with regards to usage of samples in subsequent downstream processes, reducing the risk of repeat experiments. These benefits can result in significant time and cost savings while at the same time increasing the quality of data output with significant advantages in research, applied and clinical markets.”

“This agreement significantly boosts the market reach of our spectrometry technology”, said Yvan Sergeant, VP Commercial Operations of Trinean. “It combines microfluidics with innovative spectral content profiling software for accurate quantitation of biological samples and further illustrates the importance of our ability to have a sound purity check of biological samples prior to any genetic test.”

The QIAxpert is a customized version of the Xpose reader, launched by Trinean early 2013. The platform redefines manual UV/VIS quantification into a convenient, high speed solution. The drop and read approach avoids time-consuming sample loading and cleaning steps thereby minimizing the hands-on time on the reader.

The full-color touch screen gives single touch access to advanced analytical software, including dye-free specific quantification of DNA, RNA or protein in samples containing interfering components, using Trinean’s proprietary algorithms for UV/VIS spectral deconvolution.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Trinean to be Awarded ISO 9001:2008 Certification
Certification awarded for Trinean’s Quality Management System.
Tuesday, February 03, 2015
Trinean to Appoint New Board Member
Company announced that it appointed Mr Chris van Ingen as independent board member.
Friday, May 02, 2014
Trinean Signs a Global Agreement with Bayer CropScience
Bayer will use Trinean’s technology for biomolecule QC using spectral content profiling.
Wednesday, June 12, 2013
Trinean Secures 1 Million Euro Financing
Capricorn Health-tech Fund to join the investor base.
Wednesday, May 29, 2013
Trinean Appoints New CEO and Secures 2.7 Million Euro Financing
Appointment of Philippe Stas as Company’s new CEO.
Monday, April 30, 2012
Scientific News
Michigan Researchers Use Raman Spectroscopy
inVia confocal Raman microscope used in the study of various childhood diseases.
Pittcon Announces Sanford Asher as Recipient of the 2016 SACP Award
Asher will accept this prestigious award at Pittcon 2016 in Atlanta, Georgia.
Metamaterial Absorbers for Infrared Inspection Technologies
A metamaterial absorber capable of highly sensitive infrared detection enhances the spectroscopy of tiny molecular details.
Pancreatic Cancer Stem Cells Could be "Suffocated" by Anti-diabetic Drug
A new study shows that pancreatic cancer stem cells (PancSCs) are virtually addicted to oxygen-based metabolism, and could be “suffocated” with a drug already used to treat diabetes.
Marzipan Made From Pure Almonds
Researchers carry out DNA analyses and use advanced protein identification techniques to determine whether marzipan is made from pure almonds or also contains other nuts or beans.
Evidence of Ancient Life Discovered Deep Below the Seafloor
Ancient rocks harbored microbial life deep below the seafloor, reports a team of scientists from the Woods Hole Oceanographic Institution (WHOI), Virginia Tech, and the University of Bremen.
Kwansei Gakuin University in Hyogo, Japan, Uses Raman Microscopy
Raman Microscopy study crystallographic defects in silicon carbide wafers.
Structural Discoveries Could Aid in Better Drug Design
Scientists have uncovered the structural details of how some proteins interact to turn two different signals into a single integrated output.
X-ray Laser Experiment Could Help in Designing Drugs for Brain Disorders
Scientists found that when two protein structures in the brain join up, they act as an amplifier for a slight increase in calcium concentration, triggering a gunshot-like release of neurotransmitters from one neuron to another.
Team Identifies Structure of Tumor-Suppressing Protein
An international group of researchers led by Carnegie Mellon University physicists Mathias Lösche and Frank Heinrich have established the structure of an important tumor suppressing protein, PTEN.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos